Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
EDMONTON, Alberta, June 27, 2013 (GLOBE NEWSWIRE) -- Isotechnika Pharma Inc. (TSX:ISA) (“Isotechnika” or the “Company”) and privately-held Aurinia Pharmaceuticals Inc. (“Aurinia”) issued a further update today with respect to the proposed merger of the two companies designed to create a premier clinical stage pharmaceutical company focused on the global nephrology market.
Help employers find you! Check out all the jobs and post your resume.
